Effective tuberculosis (TB) treatment has been available for the past 60 years. But TB remains the leading cause of death from a single infectious agent. It ranks above HIV and AIDS and others. This is partly because of the impact of HIV co-infection among TB patients in places like Africa and emergency of MDR-XDR TB. Lack of both gender mainstreaming and reduction of stigma manifested by persistently lower reported cases among women that men is of continued concern. Progress in TB elimination was being made. But the COVID-19 pandemic and associated lockdowns have set back TB control programmes worldwide. More so in Africa. While COVID-19 prevention measures like mask-wearing could have prevented TB transmission, on the whole, little attention was given to holding the forts of TB prevention and treatment as all efforts went to fighting the COVID-19 pandemic, disrupting well-functioning programmes built over decades of careful research and planning.
SOURCE: THE CONVERSATION
More Stories
Mo Ibrahim’s Index Looks at Africa’s State of Governance
France to Give Burkina Faso What It Wants
Africa Has to Work on Feeding Itself
Mali Basketballer Disappointed with Treatment after Whistleblowing
Kenya Changes the Rules of Engagement
For Many, the Pope’s Visit is the Peace they Need
Algeria Unveils Series of Policies Aimed at Eliminating its Dependence on Fossil Fuels
Lagos Seaport Garners Support from the Masses
Sierra Leone Women Given Right to Own Land
History About East Africa’s Art Scene
Uganda Launches its First Oil Drilling Programme
Looking at a Decade of Uber’s Operations in Africa